In Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest published in the New England Journal of Medicine in 2016, what was the authors’ conclusion regarding outcomes in patients with out-of-hospital cardiac arrest due to initial shock-refractory ventricular fibrillation or pulseless ventricular tachycardia?